Emerging Markets Physician & Payer Forum

 

 

Key Users

Global Market Research
Global Government Affairs
New Product Planning
Commercial Analysis

 

 

Physician & Payer Insights of New and Growing Pharmaceutical Markets

• Download brochure
  

Emerging Markets Physician & Payer Forum is the industry’s only syndicated primary market research product that includes insights from both physicians and payers to get a true sense of how both parties shape key emerging markets. Emerging Markets Physician & Payer Forum offers analysis of China, South Korea, Brazil and Mexico.

Emerging Markets Physician & Payer Forum enables drug developers to understand how payer policy actually impacts prescribing practices in the real world. By drawing on insights from physicians and payers, Emerging Markets Physician & Payer Forum pinpoints key market access levers and barriers that highlight what will drive or restrict a brand’s performance, so that drug developers can invest in the most appropriate market access solutions.

By understanding the viewpoints and prescribing habits of physicians and the perspectives of payers, drug developers and marketers can better prepare for key market events that are critical to their success. Emerging Markets Physician & Payer Forum reports feature direct feedback from clinicians with large practices as well as viewpoints from payers and insight into the impact of events on specific markets. Each report is based on surveys with 100 practicing physicians and interviews with eight payers. All interviewed payers are decision-makers involved in determining and regulating access to key brands under study.

Each report gives you:

• Analysis of primary data from prescribers and payers by therapeutic area experts and market access experts
• Bottom-line impact of survey results; Decision Resources’ analysts break down the key survey findings to reveal the financial “so what?” of the results
• Commercial context; each report provides a concise, targeted analysis of the business background necessary to understand the context of the research. Key epidemiological data, key disease targets, and a summary of attributes of key drugs, highlighting their strengths and weaknesses, help optimize strategic planning